Download Free Medical Next Generation Sequencing Approach to Desmoid Tumors PowerPoint Presentation

Next Generation Sequencing Approach to Desmoid Tumors PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Desmoid Tumor, which is titled "Next Generation Sequencing Approach to Desmoid Tumors", to know whether we can distinguish aggressive desmoids from those that are indolent and whether we can distinguish recurrent desmoid tumors from scars.

Tags : Desmoid Tumor, Sequencing Approach, Desmoid Tumors, aggressive desmoids, indolent

Published on : May 13, 2021 | Views : 1427 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Next Generation Sequencing Approach to Desmoid Tumors Matt van de Rijn
Slide 2-

Which questions do we hope to address? Can we distinguish aggressive desmoids from those that are indolent? Can we distinguish recurrent desmoid tumors from scars?
Slide 3-

What do we need to know about biology? Each human cell contains a nucleus where the information for >20,000 genes resides Previously we could study genes one at a time Now can look at all of them simultaneously
Slide 4-

DNA RNA mRNA protein Matt’s (simple) view of the cell:
Slide 5-

Matt’s (simple) view of the cell: In each human cell: DNA: 3 billion basepairs mRNA: >20,000 genes
Slide 6-

What is “next generation sequencing”? New technology in molecular biology that allows us to do work that used to take several years in one week First human genome took 10 years to sequence at a cost of >2 billion dollars Now can be done within a week at <$5,000
Slide 7-

Dramatic shift in approach: Rather than sequencing long stretches of DNA (~700 bases) in relatively few experiments, we now sequence millions of very short fragments and let the computer figure out the overlap
Slide 8-

3SEQ Uses Illumina Genome Analyzer for precise quantification of genome-wide mRNA expression levels on both frozen tissues and paraffin blocks PLoS One 2010, 5:e8768)
Slide 9-

What’s a Paraffin Tissue Block?
Slide 10-

ppt slide no 10 content not found
Slide 11-

Gene expression profiling by 3SEQ RNAseq DNAseq
Slide 12-

Applications of paraffin block-based “3SEQ” Gene expression profiling -Characterization of fibroblastic lesions -Comparing desmoid tumors to scars Study of lncRNA expression as potential biomarker
Slide 13-

Fibromatosis Elastofibroma Fibr Tendon Sheath Sol Fibrous tumor collagenous fibroma (6) elastofibroma (4) infantile digital fibromatosis (3) palmar fibromatosis (8) nasopharyngeal angiofibroma (6) fibroma of tendon sheath (4) nodular fasciitis (6) dermatofibrosarcoma protuberans (4) desmoid type fibromatosis (7) solitary fibrous tumor (5)
Slide 14-

We no longer rely on rare frozen tissue specimens and can use readily available paraffin blocks Goal: To generate a clinically relevant predictor of desmoid behavior Plan: Compare desmoids with known aggressive behavior with those that never recurred and determine which markers can be used to distinguish them
Slide 15-

Applications of paraffin block-based “3SEQ” Gene expression profiling -Characterization of fibroblastic lesions -Comparing desmoid tumors to scars Study of lncRNA expression as potential biomarker
Slide 16-

Problem: When a desmoid comes back, it is difficult to tell recurring desmoid from the scar of the previous surgery Preliminary studies already identify possible markers Plan: Extend these studies and validate findings
Slide 17-

Applications of paraffin block-based “3SEQ” Gene expression profiling -Characterization of fibroblastic lesions -Comparing desmoid tumors to scars Study of lncRNA expression as potential biomarker
Slide 18-

DNA RNA mRNA protein Matt’s (simple) view of the cell: lncRNA
Slide 19-

lncRNA’s detected by 3SEQ as specifically expressed in different malignancies Plan: Include desmoid tumors in this series to look for biologically relative lncRNAs
Slide 20-

Laboratory: Xiangqian Guo Sushama Varma Shirley Zhu Matt van de Rijn Rob West Santosh Gupta Trip Sweeney Erna Forgo Stanford Oncology: Kristen Ganjoo Stanford Surgery: Raffi Avedian DANA-Farber Oncology: Suzanne George Thank you!